---
title: "Zhongheng Group's subsidiary Wuzhou Pharmaceutical plans to be selected for the centralized bulk purchasing of traditional Chinese medicine by the National Traditional Chinese Medicine Procurement Alliance"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/229393249.md"
description: "Zhongheng Group's subsidiary Guangxi Wuzhou Pharmaceutical participated in the national Chinese patent medicine procurement alliance's centralized bulk procurement, with the product Thrombin Injection (Lyophilized) expected to be selected"
datetime: "2025-02-24T09:46:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/229393249.md)
  - [en](https://longbridge.com/en/news/229393249.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/229393249.md)
generator: "portal-rs"
---

# Zhongheng Group's subsidiary Wuzhou Pharmaceutical plans to be selected for the centralized bulk purchasing of traditional Chinese medicine by the National Traditional Chinese Medicine Procurement Alliance

According to the announcement from Zhongheng Group (600252.SH), the company's controlling subsidiary Guangxi Wuzhou Pharmaceutical (Group) Co., Ltd. (referred to as "Wuzhou Pharmaceutical") participated in the national traditional Chinese medicine procurement alliance's centralized bulk procurement work. Recently, according to the announcement from the National Traditional Chinese Medicine Joint Procurement Office regarding the public notice of the proposed selected and non-quoted representative products for the centralized procurement of the national traditional Chinese medicine procurement alliance, Wuzhou Pharmaceutical's product, Thrombin Injection (Lyophilized), is proposed to be selected as a non-quoted representative product for this national traditional Chinese medicine procurement alliance's centralized bulk procurement, with the proposed selected product being Thrombin Injection (Lyophilized)

### Related Stocks

- [600252.CN](https://longbridge.com/en/quote/600252.CN.md)

## Related News & Research

- [Cloud snail-mail service Docmail enters third day stuck in the outbox](https://longbridge.com/en/news/298033318.md)
- [Mabwell reports Phase Ib/IIa data showing anti-ST2 antibody 9MW1911 cuts COPD exacerbations up to 81%](https://longbridge.com/en/news/298042457.md)
- [Entertainment platform aTwist launches with microseries as Hollywood chases mobile viewers](https://longbridge.com/en/news/297894583.md)
- [China Resources Pharma unit KPC wins registration to issue RMB 1 billion in medium-term notes](https://longbridge.com/en/news/297630970.md)
- [Xiaomi builds dealer network for German market entry](https://longbridge.com/en/news/298020009.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**